Net digestive absorption and adaptive hyperphagia in adult short bowel patients

Por Crenn, P, Morin, M C, Joly, F, Penven, S, Thuillier, F, Messing, B
Publicado em 2004

Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy

Por Joly, F, Espié, M, Marty, M, Héron, J-F, Henry-Amar, M
Publicado em 2000

Impact on mental health of the COVID-19 outbreak among community pharmacists during the sanitary lockdown period

Por Lange, M., Joo, S., Couette, P.-A., de Jaegher, S., Joly, F., Humbert, X.
Publicado no Ann Pharm Fr (2020)

Biosynthesis of paf-acether. Activators of protein kinase C stimulate cultured mast cell acetyltransferase without stimulating paf-acether synthesis.

Por Joly, F, Vigrain, I, Bossant, M J, Bessou, G, Benveniste, J, Ninio, E
Publicado em 1990

A severe but reversible refractory sprue

Por Dray, X, Joly, F, Lavergne‐Slove, A, Treton, X, Bouhnik, Y, Messing, B
Publicado em 2006

Impact of COVID-19 infection in patients with chronic intestinal failure. a national experience

Por Sayed, C., Damas, V., Charpentier, C., Quilliot, D., Piquet, M.A., Dechelotte, P., Billiauws, L., Joly, F.
Publicado no Clin Nutr ESPEN (2020)

Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions

Por Schagen, S.B., Klein, M., Reijneveld, J.C., Brain, E., Deprez, S., Joly, F., Scherwath, A., Schrauwen, W., Wefel, J.S.
Publicado no EJC Suppl (2014)

Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer

Por Roberge, C, Tran, M, Massoud, C, Poirée, B, Duval, N, Damecour, E, Frout, D, Malvy, D, Joly, F, Lebailly, P, Henry-Amar1, M
Publicado em 2000

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO

Por Ray-Coquard, I, Favier, L, Weber, B, Roemer-Becuwe, C, Bougnoux, P, Fabbro, M, Floquet, A, Joly, F, Plantade, A, Paraiso, D, Pujade-Lauraine, E
Publicado em 2013

Expansion of autoreactive unresponsive CD21(-/low) B cells in Sjögren's syndrome associated lymphoproliferation

Por Saadoun, D, Terrier, B, Bannock, J, Vazquez, T, Massad, C, Kang, I, Joly, F, Rosenzwajg, M, Sene, D, Benech, P, Klatzmann, D, Meffre, E, Cacoub, P
Publicado no Arthritis Rheum (2013)

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study

Por Mouriaux, F, Servois, V, Parienti, J J, Lesimple, T, Thyss, A, Dutriaux, C, Neidhart-Berard, E M, Penel, N, Delcambre, C, Peyro Saint Paul, L, Pham, A D, Heutte, N, Piperno-Neumann, S, Joly, F
Publicado no Br J Cancer (2016)

LBA69 Impact of the COVID-19 pandemic on management of medical cancer treatments and psychological consequence for the patients

Por Joly, F., Leconte, A., Grellard, J-M., Lequesne, J., Binarelli, G., Lange, M., Tron, L., Gernier, F., Rieux, C., Fernette, M., Bastien, E., Morel, A., Legrand, B., Richard, D., Faveyrial, A., Travers, R., Pépin, L-F., Rigal, O., Jardin, F., Clarisse, B.
Publicado no Ann Oncol (2020)

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group

Por Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalbacher, E, Lortholary, A, Favier, L, Treilleux, I, Ray-Coquard, I
Publicado no Br J Cancer (2017)

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease

Por Wilson, M. K., Pujade-Lauraine, E., Aoki, D., Mirza, M. R., Lorusso, D., Oza, A. M., du Bois, A., Vergote, I., Reuss, A., Bacon, M., Friedlander, M., Gallardo-Rincon, D., Joly, F., Chang, S.-J., Ferrero, A. M., Edmondson, R. J., Wimberger, P., Maenpaa, J., Gaffney, D., Zang, R., Okamoto, A., Stuart, G., Ochiai, K.
Publicado no Ann Oncol (2017)